Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRoivant Sciences Ltd.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Roivant Sciences Ltd.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Oct 1, 2026Epperly Melissa B,Director17,750Stock Option (Right to Buy)$678.4KOption exercise
Oct 1, 2026Epperly Melissa B,Director17,750Common Shares$678.4KSell
Oct 1, 2026Epperly Melissa B,Director17,750Common Shares$678.4KExercise / conversion
Sep 30, 2026Torti FrankPresident and Vant Chair40,309Common Shares$1.5MTax withholding
Sep 30, 2026Gline MatthewCEO76,171Common Shares$2.9MTax withholding
Sep 30, 2026Venker EricPresident & Immunovant CEO200,000Stock Option (Right to Buy)$7.6MOption exercise
Sep 30, 2026Venker EricPresident & Immunovant CEO200,000Common Shares$7.6MSell
Sep 30, 2026Venker EricPresident & Immunovant CEO200,000Common Shares$7.6MExercise / conversion
Sep 30, 2026Sukhatme MayukhPresident & CIO46,879Common Shares$1.8MTax withholding
Sep 20, 2026Humes JenniferChief Accounting Officer3,880Common Shares$154.3KTax withholding
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
$38.22Close · Sep 22, 2026